Physician profile
Averi Botts
NPI 1992323059
$6,557.32
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $3,047 · 2023: $2,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,938.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,256.25 | 2021-2023 | Minimed 780g |
| Novo Nordisk INC | $1,012.22 | 2021-2023 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $790.86 | 2021-2023 | Mounjaro, Jardiance, Baqsimi |
| Sanofi-Aventis U.S. LLC | $500.52 | 2022-2023 | |
| Xeris Pharmaceuticals, INC. | $474.81 | 2021-2023 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $454.93 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $349.73 | 2022-2023 | Jardiance |
| Dexcom, INC. | $347.58 | 2021-2023 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $343.38 | 2022-2023 | Farxiga |
| Abbott Laboratories | $285.83 | 2023 | Freestyle Libre |
| Renalytix Ai, INC. | $220.53 | 2022-2023 | Kidneyintelx Blood Collection Convenience Kit |
| Lifescan, INC. | $130.41 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $90.74 | 2022-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $68.86 | 2022-2023 | Omnipod |
| Embecta Corp. | $58.75 | 2023 | Bd Nano 2nd Gen Pen Needle |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zealand Pharma US, INC. | $53.00 | 2021-2022 | |
| Corcept Therapeutics | $44.30 | 2022-2023 | Korlym |
| Esperion Therapeutics, INC. | $35.51 | 2022 | |
| Becton, Dickinson and Company | $19.16 | 2022 | |
| Grt US Holding, INC. | $14.60 | 2021 | |
| Genentech USA, INC. | $5.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Averi Botts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.